GSK puts further investment into Cork

GlaxoSmithKline (GSK) is set to invest a further $19m (€15.5m) in its research facility in Carrigaline, Cork.

GSK puts further investment into Cork

GlaxoSmithKline (GSK) is set to invest a further $19m (€15.5m) in its research facility in Carrigaline, Cork.

The drug giant will use the money to build a new pharmaceutical R&D facility that will create 10 highly skilled jobs.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited